查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1787011

放射性医药品市场，规模，占有率，趋势，产业分析报告:放射性同位元素类别，各用途，供给来源，各终端用户，各地区-2025年～2034年市场预测

Radiopharmaceuticals Market Size, Share, Trends, & Industry Analysis Report By Radioisotope Type (Technetium-99, Fluorine-18), By Application, By Source, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，放射性药物市场规模将达到 209.4 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

随着医院和影像中心越来越依赖核医进行诊断和治疗，放射性药物市场正在稳步成长。这些专用化合物用于 PET 和 SPECT 等检查，以便及早、准确地发现病变。

持续的研发正在推动新型放射性药物的开发，这些药物的准确性更高，副作用更少。因此，医疗保健机构正在投资最新的影像系统，并扩大其核子医学部门。这种转变正在改善患者的治疗效果，并提供先进的诊断和治疗服务。

放射性药物市场报告重点

按放射性同位素类型划分，锝-99 领域在 2024 年占据市场主导地位，该领域广泛应用于骨骼、心臟和肿瘤诊断相关疾病的 SPECT 成像。

按应用划分，由于放射性药物在癌症诊断、分期和治疗计划中的应用日益广泛，神经病学领域在 2024 年占据市场主导地位。

按放射源划分，由于钼-99 等同位素的广泛使用，核反应器领域在 2024 年占据市场主导地位。

北美拥有完善的核医基础设施，到2024年将占据全球放射性药物市场的大部分占有率。

由于印度、中国和韩国医疗基础设施的快速发展，亚太地区将占据相当大的市场占有率。

全球主要市场参与者包括Advanced Accelerator Applications SA、阿斯特捷利康公司、拜耳公司、勃林格殷格翰国际有限公司、Bracco Imaging S.p.A.、Cardinal Health, Inc.、Curium Pharma、Eckert & Ziegler SE、F. Hoffmann-La Roche Roche Ltd.、GEJB Technologies Ltd. Limited、Lantheus Holdings, Inc.、礼来公司和Mallinckrodt plc。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球放射性医药品市场洞察

  • 市场概述
  • 放射性医药品市场动态
    • 促进因素和机会
      • 全球癌症和心血管疾病发生率上升
      • 全球人口老化
    • 限制与挑战
      • 高昂的生产成本和复杂的监管审批
  • PESTEL分析
  • 放射性医药品市场趋势
  • 价值链分析

第5章 全球放射性医药品市场:放射性同位元素类别

  • 主要调查结果
  • 简介
  • Technetium99
  • 氟18
  • 碘131
  • 镏177
  • 钇90
  • 镓68
  • 镓67
  • 铷82
  • 碘123
  • 碘125
  • 铟111
  • 其他

第6章 全球放射性医药品市场:各用途

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 心臟病
  • 消化器官内科
  • 神经内分泌学
  • 神经学
  • 肾臟学
  • 其他

第7章 全球放射性医药品市场:供给来源展望

  • 主要调查结果
  • 简介
  • 核子反应炉
  • 迴旋加速器

第8章 全球放射性医药品市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 诊断中心
  • 癌症研究机关
  • 门诊病人手术中心
  • 其他

第9章 全球放射性医药品市场:各地区

  • 主要调查结果
  • 简介
    • 放射性医药品市场评估:地区，2020年～2034年
  • 北美
    • 北美:放射性同位元素类别，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 北美:供给来源展望，2020年～2034年
    • 北美:各终端用户，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:放射性同位元素类别，2020年～2034年
    • 欧洲:各用途，2020年～2034年
    • 欧洲:供给来源展望，2020年～2034年
    • 欧洲:各终端用户，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:放射性同位元素类别，2020年～2034年
    • 亚太地区:各用途，2020年～2034年
    • 亚太地区:供给来源展望，2020年～2034年
    • 亚太地区:各终端用户，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:放射性同位元素类别，2020年～2034年
    • 中东·非洲:各用途，2020年～2034年
    • 中东·非洲:供给来源展望，2020年～2034年
    • 中东·非洲:各终端用户，2020年～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:放射性同位元素类别，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 南美:供给来源展望，2020年～2034年
    • 南美:各终端用户，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Advanced Accelerator Applications SA
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bracco Imaging S.p.A.
  • Cardinal Health, Inc.
  • Curium Pharma
  • Eckert & Ziegler SE
  • F. Hoffmann-La Roche Ltd
  • GE HealthCare Technologies Inc.
  • GlaxoSmithKline plc(GSK plc)
  • Jubilant Radiopharma Limited
Product Code: PM6029

The radiopharmaceuticals market size is expected to reach USD 20.94 Billion by 2034, according to a new study by Polaris Market Research. The report "Radiopharmaceuticals Market Size, Share, Trends, & Industry Analysis Report By Radioisotope Type (Technetium-99, Fluorine-18), By Application, By Source, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The radiopharmaceuticals market is growing steadily as hospitals and imaging centers increasingly rely on nuclear medicine for both diagnosis and treatment. These specialized compounds are used in scans such as PET and SPECT to detect conditions early and accurately.

Ongoing research is leading to the development of new radiopharmaceuticals that are more precise and contains fewer side effects. Therefore, healthcare providers are investing in modern imaging systems and expanding nuclear medicine departments. This shift is improving patient outcomes, providing advanced diagnostic and therapeutic services.

Radiopharmaceuticals Market Report Highlights

Based on radioisotope type, the technetium-99 segment dominated the market in 2024, due to its widespread application in SPECT imaging for conditions related to bone, cardiac, and oncology diagnostics.

In terms of application, the neurology segment dominated the market in 2024. This is owing the growing adoption of radiopharmaceuticals in cancer diagnosis, staging, and treatment planning.

In terms of source, the nuclear reactors segment dominated the market in 2024, due to the extensive use of isotopes such as molybdenum-99.

North America accounted for the majority share in the global Radiopharmaceuticals market in 2024, due to advanced nuclear medicine infrastructure.

Asia Pacific held substantial market share, owing to rapid growth in healthcare infrastructure across India, China, and South Korea.

A few global key market players include Advanced Accelerator Applications SA, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Bracco Imaging S.p.A., Cardinal Health, Inc., Curium Pharma, Eckert & Ziegler SE, F. Hoffmann-La Roche Ltd, GE HealthCare Technologies Inc., GlaxoSmithKline plc (GSK plc), Jubilant Radiopharma Limited, Lantheus Holdings, Inc., Eli Lilly and Company, and Mallinckrodt plc.

Polaris Market Research has segmented the market report on the basis of type, application, source, end user, and region:

By Radioisotope Type Outlook (Revenue, USD Billion, 2020-2034)

Technetium-99

Fluorine-18

Iodine-131

Lutetium-177

Yttrium-90

Gallium-68

Gallium-67

Rubidium-82

Iodine-123

Iodine-125

Indium-111

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Cardiology

Gastroenterology

Neuroendocrinology

Neurology

Nephrology

Others

By Source Outlook (Revenue, USD Billion, 2020-2034)

Nuclear Reactors

Cyclotrons

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Diagnostic Centers

Cancer Research Institutes

Ambulatory Surgical Centers

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Radiopharmaceuticals Market Insights

  • 4.1. Radiopharmaceuticals Market - Market Snapshot
  • 4.2. Radiopharmaceuticals Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Number of Cancer and Cardiovascular Diseases Globally
      • 4.2.1.2. Aging Global Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Production Costs and Complex Regulatory Approvals
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Radiopharmaceuticals Market Trends
  • 4.6. Value Chain Analysis

5. Global Radiopharmaceuticals Market, by Radioisotope Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • 5.3. Technetium-99
    • 5.3.1. Global Radiopharmaceuticals Market, by Technetium-99, by Region, 2020-2034 (USD Billion)
  • 5.4. Fluorine-18
    • 5.4.1. Global Radiopharmaceuticals Market, by Fluorine-18, by Region, 2020-2034 (USD Billion)
  • 5.5. Iodine-131
    • 5.5.1. Global Radiopharmaceuticals Market, by Iodine-131, by Region, 2020-2034 (USD Billion)
  • 5.6. Lutetium-177
    • 5.6.1. Global Radiopharmaceuticals Market, by Lutetium-177, by Region, 2020-2034 (USD Billion)
  • 5.7. Yttrium-90
    • 5.7.1. Global Radiopharmaceuticals Market, by Yttrium-90, by Region, 2020-2034 (USD Billion)
  • 5.8. Gallium-68
    • 5.8.1. Global Radiopharmaceuticals Market, by Gallium-68, by Region, 2020-2034 (USD Billion)
  • 5.9. Gallium-67
    • 5.9.1. Global Radiopharmaceuticals Market, by Gallium-67, by Region, 2020-2034 (USD Billion)
  • 5.10. Rubidium-82
    • 5.10.1. Global Radiopharmaceuticals Market, by Rubidium-82, by Region, 2020-2034 (USD Billion)
  • 5.11. Iodine-123
    • 5.11.1. Global Radiopharmaceuticals Market, by Iodine-123, by Region, 2020-2034 (USD Billion)
  • 5.12. Iodine-125
    • 5.12.1. Global Radiopharmaceuticals Market, by Iodine-125, by Region, 2020-2034 (USD Billion)
  • 5.13. Indium-111
    • 5.13.1. Global Radiopharmaceuticals Market, by Indium-111, by Region, 2020-2034 (USD Billion)
  • 5.14. Others
    • 5.14.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Radiopharmaceuticals Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • 6.3. Oncology
    • 6.3.1. Global Radiopharmaceuticals Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 6.4. Cardiology
    • 6.4.1. Global Radiopharmaceuticals Market, by Cardiology, by Region, 2020-2034 (USD Billion)
  • 6.5. Gastroenterology
    • 6.5.1. Global Radiopharmaceuticals Market, by Gastroenterology, by Region, 2020-2034 (USD Billion)
  • 6.6. Neuroendocrinology
    • 6.6.1. Global Radiopharmaceuticals Market, by Neuroendocrinology, by Region, 2020-2034 (USD Billion)
  • 6.7. Neurology
    • 6.7.1. Global Radiopharmaceuticals Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 6.8. Nephrology
    • 6.8.1. Global Radiopharmaceuticals Market, by Nephrology, by Region, 2020-2034 (USD Billion)
  • 6.9. Others
    • 6.9.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Radiopharmaceuticals Market, by Source Outlook

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • 7.3. Nuclear Reactors
    • 7.3.1. Global Radiopharmaceuticals Market, by Nuclear Reactors, by Region, 2020-2034 (USD Billion)
  • 7.4. Cyclotrons
    • 7.4.1. Global Radiopharmaceuticals Market, by Cyclotrons, by Region, 2020-2034 (USD Billion)

8. Global Radiopharmaceuticals Market, by End User

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Radiopharmaceuticals Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 8.4. Diagnostic Centers
    • 8.4.1. Global Radiopharmaceuticals Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
  • 8.5. Cancer Research Institutes
    • 8.5.1. Global Radiopharmaceuticals Market, by Cancer Research Institutes, by Region, 2020-2034 (USD Billion)
  • 8.6. Ambulatory Surgical Centers
    • 8.6.1. Global Radiopharmaceuticals Market, by Ambulatory Surgical Centers, by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Radiopharmaceuticals Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Radiopharmaceuticals Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Radiopharmaceuticals Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. Radiopharmaceuticals Market - North America
    • 9.3.1. North America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.3.2. North America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.3.3. North America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.3.4. North America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.3.5. Radiopharmaceuticals Market - U.S.
      • 9.3.5.1. U.S.: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.3.6. Radiopharmaceuticals Market - Canada
      • 9.3.6.1. Canada: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.4. Radiopharmaceuticals Market - Europe
    • 9.4.1. Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.4.2. Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.4.3. Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.4.4. Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.5. Radiopharmaceuticals Market - UK
      • 9.4.5.1. UK: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.6. Radiopharmaceuticals Market - France
      • 9.4.6.1. France: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.6.2. France: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.3. France: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.6.4. France: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.7. Radiopharmaceuticals Market - Germany
      • 9.4.7.1. Germany: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.8. Radiopharmaceuticals Market - Italy
      • 9.4.8.1. Italy: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.9. Radiopharmaceuticals Market - Spain
      • 9.4.9.1. Spain: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.10. Radiopharmaceuticals Market - Netherlands
      • 9.4.10.1. Netherlands: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.11. Radiopharmaceuticals Market - Russia
      • 9.4.11.1. Russia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.4.12. Radiopharmaceuticals Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.5. Radiopharmaceuticals Market - Asia Pacific
    • 9.5.1. Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.5. Radiopharmaceuticals Market - China
      • 9.5.5.1. China: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.5.2. China: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.3. China: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.5.4. China: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.6. Radiopharmaceuticals Market - India
      • 9.5.6.1. India: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.6.2. India: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.3. India: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.6.4. India: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.7. Radiopharmaceuticals Market - Malaysia
      • 9.5.7.1. Malaysia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.8. Radiopharmaceuticals Market - Japan
      • 9.5.8.1. Japan: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.9. Radiopharmaceuticals Market - Indonesia
      • 9.5.9.1. Indonesia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.10. Radiopharmaceuticals Market - South Korea
      • 9.5.10.1. South Korea: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.11. Radiopharmaceuticals Market - Australia
      • 9.5.11.1. Australia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.5.12. Radiopharmaceuticals Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.6. Radiopharmaceuticals Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.6.5. Radiopharmaceuticals Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.6.6. Radiopharmaceuticals Market - UAE
      • 9.6.6.1. UAE: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.6.7. Radiopharmaceuticals Market - Israel
      • 9.6.7.1. Israel: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.6.8. Radiopharmaceuticals Market - South Africa
      • 9.6.8.1. South Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.6.9. Radiopharmaceuticals Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • 9.7. Radiopharmaceuticals Market - Latin America
    • 9.7.1. Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.7.5. Radiopharmaceuticals Market - Mexico
      • 9.7.5.1. Mexico: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.7.6. Radiopharmaceuticals Market - Brazil
      • 9.7.6.1. Brazil: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.7.7. Radiopharmaceuticals Market - Argentina
      • 9.7.7.1. Argentina: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
    • 9.7.8. Radiopharmaceuticals Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Advanced Accelerator Applications SA
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AstraZeneca plc
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bayer AG
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Boehringer Ingelheim International GmbH
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Bracco Imaging S.p.A.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Cardinal Health, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Curium Pharma
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Eckert & Ziegler SE
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. F. Hoffmann-La Roche Ltd
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GE HealthCare Technologies Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. GlaxoSmithKline plc (GSK plc)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Jubilant Radiopharma Limited
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 2 Global Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 3 Global Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 4 Global Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 5 North America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 6 North America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 7 North America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 8 North America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 9 U.S.: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 10 U.S.: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 11 U.S.: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 12 U.S.: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 13 Canada: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 14 Canada: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 15 Canada: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 16 Canada: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 18 Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 19 Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 20 Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 21 UK: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 22 UK: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 23 UK: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 24 UK: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 25 France: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 26 France: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 27 France: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 28 France: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 29 Germany: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 30 Germany: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 31 Germany: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 32 Germany: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Italy: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 34 Italy: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 35 Italy: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 36 Italy: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Spain: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 38 Spain: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 39 Spain: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 40 Spain: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Netherlands: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 42 Netherlands: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 43 Netherlands: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 44 Netherlands: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Russia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 46 Russia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 47 Russia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 48 Russia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 57 China: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 58 China: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 59 China: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 60 China: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 61 India: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 62 India: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 63 India: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 64 India: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Malaysia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 66 Malaysia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 67 Malaysia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 68 Malaysia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 69 Japan: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 70 Japan: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 71 Japan: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 72 Japan: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 73 Indonesia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 74 Indonesia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 75 Indonesia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 76 Indonesia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 77 South Korea: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 78 South Korea: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 79 South Korea: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 80 South Korea: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 81 Australia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 82 Australia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 83 Australia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 84 Australia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 97 UAE: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 98 UAE: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 99 UAE: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 100 UAE: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 101 Israel: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 102 Israel: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 103 Israel: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 104 Israel: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 105 South Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 106 South Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 107 South Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 108 South Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 113 Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 114 Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 115 Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 116 Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 117 Mexico: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 118 Mexico: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 119 Mexico: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 120 Mexico: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 121 Brazil: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 122 Brazil: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 123 Brazil: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 124 Brazil: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 125 Argentina: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 126 Argentina: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 127 Argentina: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 128 Argentina: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: Radiopharmaceuticals Market, by Radioisotope Type, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: Radiopharmaceuticals Market, by Application, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: Radiopharmaceuticals Market, by Source Outlook, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: Radiopharmaceuticals Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Radiopharmaceuticals Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Radioisotope Type
  • Figure 7. Global Radiopharmaceuticals Market, by Radioisotope Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Application
  • Figure 9. Global Radiopharmaceuticals Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Source Outlook
  • Figure 11. Global Radiopharmaceuticals Market, by Source Outlook, 2024 & 2034 (USD Billion)
  • Figure 12. Market by End User
  • Figure 13. Global Radiopharmaceuticals Market, by End User, 2024 & 2034 (USD Billion)